Optimus Pharma is a finished-dose manufacturer based in India. It appears in 33 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with CDSCO (India), US FDA and UZPHARM (UZ). Its GMP standing is certified by EAEU_EEC, EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 23 June 2023 as VAI. Customs aggregates show $1.2M of exports covering 31 molecules to 8 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Sangareddy, India | 3013914542 |
| Isnapur, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 29 | None |
| US FDA | 3 | 1 |
| UZPHARM (UZ) | 1 | None |
| EAEU_EEC | None | 2 |
| EMA | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $46K | 1 |
| 2025 | Not reported | $1.2M | 8 |
| 2024 | Not reported | $2.1M | 5 |
| 2023 | Not reported | $1.5M | 5 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Optimus Pharma comes back tiered against every other supplier able to file there.
Start for free